Skip to content

endovascular procedure to widen narrowed or obstructed arteries or veins of lower limbs in patients suffering from diabetes

Evaluation of Safety and efficacy of Infrapopliteal angioplasty for Diabetic Foot

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016041018457N3
Enrollment
41
Registered
2016-09-24
Start date
2015-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E11.621. Diabetes type 2 with lower limb circulation disorder

Interventions

Intervention group 1 :Infrapopliteal Angioplasty . Diabetic foot angiography process using antegrade and retrograde puncture . By the case of infrapopliteal narrowing , Task2 classification. hyd
Treatment - Other
Intervention group 1 :Infrapopliteal Angioplasty . Diabetic foot angiography process using antegrade and retrograde puncture . By the case of infrapopliteal narrowing , Task2 classification.

Sponsors

Vice chancellor for Research -Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion Criteria : 1-chronic Diabetic Patients with chronic wounds or gangren 2- or Ankle Brachial index 1.3 mg/dl ) 2- Progressive Diabet 3- Severe Occlusions 4- Pregnancy 5- age under 18 years

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Ankle barachial index. Timepoint: before operation , 1 and 6 months after surgery. Method of measurement: By Infectious disease subspeciality physician.;Minor tissue loss. Timepoint: before operation , 1 and 6 months after surgery. Method of measurement: By Infectious disease subspeciality physician.;Non-healing and chronic wounds. Timepoint: before operation , 1 and 6 months after surgery. Method of measurement: By Infectious disease subspeciality physician.;Compatment Syndrome. Timepoint: before operation , 1 and 6 months after surgery. Method of measurement: By Infectious disease subspeciality physician.;High Blood Pressure. Timepoint: before operation , 1 and 6 months after surgery. Method of measurement: By Infectious disease subspeciality physician.;Fasting Blood suger. Timepoint: before operation , 1 and 6 months after surgery. Method of measurement: By Infectious disease subspeciality physician.;Blood Cholestrol Levels. Timepoint: before operation , 1 and 6 months after surgery. Method of measurement: By Infectious disease subspeciality physician.;Renal Failure. Timepoint: before operation , 1 and 6 months after surgery. Method of measurement: labratorary Measurements.;Rest time pain. Timepoint: before operation , 1 and 6 months after surgery. Method of measurement: By Infectious disease subspeciality physician.;Myocardial Infarction new episode. Timepoint: before operation , 1 and 6 months after surgery. Method of measurement: By Infectious disease subspeciality physician and ask from patient.

Secondary

MeasureTime frame
Major Tissue Loss. Timepoint: Before, 1 and 6 months after surgery. Method of measurement: By infectious Disease Subspeciality physician.;Major Amputation after surgery. Timepoint: Before, 1 and 6 months after surgery. Method of measurement: By infectious Disease Subspeciality physician.;Pulmonary Edema after surgery. Timepoint: Before, 1 and 6 months after surgery. Method of measurement: By infectious Disease Subspeciality physician.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParto Sabetrasekh

Medical Imaging Center

parto_s_r@yahoo.com+98 21 6658 1579

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026